Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer

Fig. 2

a TP53 gene status in tumor tissue of patients and its association with copy number alterations (CNA) in the SOX2 gene. **p = 0.017, was obtained from unconditional logistic regression, adjusted for age, gender, total pack-years and histology (n = 229). b Correlation between the relative SOX2 and TP53 mRNA expression. r = 0.447, p = 0.013 was obtained from Spearman's Rank-Order Correlation (n = 30)

Back to article page
\